Skip to main content

Animations

MJFF Publications

4671 - 4680 of 8823 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-020-00388-2
    Citation Count: 91
  • Summary Details
    OPEN
    Title: A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-020-00412-5
    Citation Count: 63
  • Summary Details
    RESTRICTED
    Title: When antibodies mislead: the quest for validation
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/d41586-020-02549-1
    Citation Count: 45
  • Summary Details
    OPEN
    Title: All that’s fit to preprint
    Journal Name: Nature Biotechnology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41587-020-0536-x
    Citation Count: 11
  • Summary Details
    OPEN
    Title: α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-020-15626-w
    Citation Count: 383
  • Summary Details
    OPEN
    Title: Molecular estimation of neurodegeneration pseudotime in older brains
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-020-19622-y
    Citation Count: 71
  • Summary Details
    RESTRICTED
    Title: Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41586-020-1984-7
    Citation Count: 815
  • Summary Details
    OPEN
    Title: Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-019-14279-8
    Citation Count: 473
  • Summary Details
    RESTRICTED
    Title: Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41591-020-0755-1
    Citation Count: 1222
  • Summary Details
    OPEN
    Title: Common diseases alter the physiological age-related blood microRNA profile
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-020-19665-1
    Citation Count: 111
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.